U.S. earmarks $19 billion for eHealth Pristiq: new antidepressantWyeth is introducing Pristiq (desvenlafaxine 50 mg and 100 mg extended-release tablets) for the symptomatic relief of major depressive disorder in adults. CFP announces new president Peter Marshall has been appointed president of the Canadian Foundation for Pharmacy for 2009. Lax-A-Day: new PEG oral laxative PendoPharm/Pharmascience is introducing a new OTC osmotic laxative, Lax-A-Day (polyethylene glycol [PEG] 3350 powder for oral solution). New indication for Aclasta Novartis' Aclasta (zoledronic acid injection) is now approved for use as a once-yearly intravenous (IV) infusion in the prevention and treatment of corticosteroid-induced osteoporosis, to increase bone mineral density. ORTHOPEDICS: Canadians debunk hip resurfacing hype Meeting also highlights growing concern over adverse reactions to metal-on-metal implants Doctors' environmental group sees tenfold rise in members since 2006 Don't let terminal diagnosis end patient communicaiton DIGESTIVE DISEASES: Endoscopy review finds long waits for patients with serious symptoms Negative thoughts make pain worse First Previous 2462 2463 2464 2465 2466 Next Last
